Skip to main content
Contact
Submit RFP

      The aftermath of the Covid-19 pandemic and the changed geopolitical situation, characterised by political tensions and armed conflicts, has led the life sciences and chemicals industry into a new, more volatile era.

      Companies are required to become much more agile, digital and networked in their respective ecosystems. The change and individualisation of customer needs remains one of the biggest challenges. However, topics such as digital transformation, stable supply chains, holistic sustainability, geopolitics and trade conflicts are also at the centre of attention for life sciences and chemical companies.  

      Becoming more agile, digital and networked in the ecosystems

      Compared to other sectors, the healthcare industry and life sciences companies still have some catching up to do when it comes to digitalisation. This applies in particular to the areas of digital therapies, patient and doctor interactions as well as digitalisation in research and development and production. Collaboration with start-ups and technology companies can make a big difference here.

      In addition, life sciences companies must improve their ESG balance sheet by steadily expanding their social contribution to even broader and affordable healthcare in addition to decarbonisation. However, sharply rising raw material prices, their availability, the stability of the energy supply and increased sustainability requirements also pose serious challenges for companies.

      The development of resilient supply networks, the adjustment of the energy mix and further digitalisation will play a decisive role in the future.

      Our experts will help you to better position your company for the future and support you in the transformation to a more customer-centred and competitive company.

      Companies in the life sciences industry are required to become much more agile, digital and networked in their respective ecosystems. The development of resilient supply networks, the adaptation of the energy mix and further digitalisation will play a decisive role in the future.

      Stephan Fetsch
      Stephan Fetsch

      Partner, Deal Advisory, EMA und German Head of Retail & Consumer Goods

      KPMG AG Wirtschaftsprüfungsgesellschaft

      Focus on industry topics

      Chemicals 4.0: How the chemical industry is implementing ESG

      The chemical industry is in a decisive phase of transformation. We show you what is important.

      Download now
      Windkraftanlagen und Sonnenblume

      Our range of services

      KPMG supports you in mastering these challenges. Our services are customised to meet the needs of our clients. We offer you flexible and well-coordinated teams that comprehensively cover the auditing and advisory needs of your company. In addition, our integration into a global network enables us to quickly identify current trends.

      Our employees are not only specialists in their fields. They also have industry-specific expertise, which we pool in our Chemicals and Pharmaceuticals sector.

      • We support and advise you on topics such as
        • Strategies and concepts for investments in new markets
        • Portfolio optimisation (e.g. carve-out)
        • Acquisition and sale of (parts of) companies in Germany and abroad
        • Transaction consulting (e.g. due diligence)
        • Company valuation (e.g. purchase price allocation)
        • Integration consulting
        • Restructuring
        • Support with initial public offerings (IPO)
        • IT consulting
        • Cyber security
        • Digital transformation
        • Research & development - optimisation and controlling
        • Supply chain optimisation
        • Profitability and cost optimisation
        • Mass data analysis (big data)
        • Tax mapping of changed value creation processes
      • In the Audit and Tax divisions, we can assist you with the following topics, among others:
        • Audit of annual and consolidated financial statements
        • Audit of sustainability information and reports
        • Climate reporting and CO2 balances
        • Auditing of management systems for the environment, energy, occupational safety and quality
        • Support in connection with M&A cases, national and international
        • EUGH case law - application and implementation
        • Transfer pricing planning and subsequent operational implementation and automation (operational transfer pricing) as well as transfer pricing compliance
        • Global mobility services (e.g. international employee deployment)
        • Indirect tax services (e.g. value added tax, customs law)
      Interested in our services? Contact us

      Do you need advice in the life sciences sector?

       
      Are you interested in more details about our work and would like to arrange a meeting with us? Then simply contact us via the following channels - we look forward to hearing from you!

      Contact us

      Five challenges for the new reality

      Differentiated expectations of customers and patients when it comes to digital medical products and services. The demographic shift in the customer base towards the digital native customer is a long-term process that is gaining exorbitant importance in times of far-reaching contact restrictions.

      Inevitable switch to digital communication and interaction channels. Companies should proactively drive the introduction of digital channels and at the same time close the gap between comprehensive data security and intelligent data processing.

      Increasing recognition of the economic relevance of digitalisation and automation measures in production processes in the chemical and pharmaceutical industries. Legal contact restrictions should not affect operations.

      Lengthy development and market launch process for new drugs and therapies. The main challenge here is to adopt new healthcare regulations and standards while remaining competitive.

      The uncertain development of demand in the core sales sectors for the chemical industry (e.g. automotive industry) requires the far-reaching development of new, digital business models.

      More KPMG Insights

      Newsletter

      The latest news and trends from the life sciences sector - delivered to your mailbox free of charge.

      attach_email

      Stay well informed about transactions in the global chemicals industry
      Register now
      attach_email

      Stay well informed about transactions in the global life sciences industry
      Register now

      Your contacts